Most Read Articles
Jairia Dela Cruz, 4 days ago
The potassium-competitive acid blocker vonoprazan demonstrates superior efficacy in the treatment of patients with erosive oesophagitis compared with the proton pump inhibitor lansoprazole, with the results of a small trial showing that the former more rapidly provides complete sustained heartburn relief during the first week of therapy.
01 Mar 2016
Bathing with 2% chlorhexidine gluconate-medicated washcloth is cost-effective for the prevention of central line-associated bloodstream infection (CLABSI), based on a systematic review and meta-analysis of four studies.
31 May 2016
Tacrolimus is safe and effective in inducing and maintaining remission in paediatric patients with biologic refractory inflammatory bowel disease (IBD), according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Athens, Greece.
Rachel Soon, 25 Jul 2018

MIMS Pharmacist presents an overview of Lactobacillus plantarum 299v's physiological role, as well as contemporary research on its pharmacology and effects.

Intravesical gentamicin instillation cuts number of UTI episodes

09 Nov 2018

Intravesical instillation of gentamicin appears to result in reduced number of urinary tract infection (UTI) episodes and degree of antimicrobial resistance, a study has shown.

The study included 63 adults with recurrent UTI caused by multidrug-resistant (MDR) pathogens. All of them received overnight intravesical gentamicin instillations for 6 months.

Recurrence rate of UTIs, the primary study outcome, dropped from 4.8 at baseline to 1.0 during intravesical treatment. The secondary outcome of resistance to uropathogens also improved, with the rate falling from 78 percent to 23 percent.

In terms of safety, there were no reports of systemic absorption or clinically relevant side effects.

Intravesical instillations have long been used in urology, mostly for treating nonmuscle invasive bladder cancer. Gentamicin is believed to be an ideal antibiotic for intravesical instillation, having been shown to be bactericidal against most gram-negative genitourinary pathogens including some multiresistant organisms. Intravenous use of this drug is limited by potential nephrotoxic and ototoxic effects, although the bladder provides an impermeable surface and allows the drug to be concentrated at high levels in the target area. Another advantage of not administering it systemically is the avoidance of side effects such as nausea, diarrhoea and colonic superinfection. [Int J Antimicrob Agents 2010;36:485-490]

Recurrent UTIs are a common problem, negatively affecting quality of life and possibly requiring hospital admission. About one-third of females will have a UTI in their lifetime, with evidence showing that 24–50 percent of them will have a recurrence within 6 months of the index infection. [Neurourol Urodyn 2017;36:2109-2116]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 4 days ago
The potassium-competitive acid blocker vonoprazan demonstrates superior efficacy in the treatment of patients with erosive oesophagitis compared with the proton pump inhibitor lansoprazole, with the results of a small trial showing that the former more rapidly provides complete sustained heartburn relief during the first week of therapy.
01 Mar 2016
Bathing with 2% chlorhexidine gluconate-medicated washcloth is cost-effective for the prevention of central line-associated bloodstream infection (CLABSI), based on a systematic review and meta-analysis of four studies.
31 May 2016
Tacrolimus is safe and effective in inducing and maintaining remission in paediatric patients with biologic refractory inflammatory bowel disease (IBD), according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Athens, Greece.
Rachel Soon, 25 Jul 2018

MIMS Pharmacist presents an overview of Lactobacillus plantarum 299v's physiological role, as well as contemporary research on its pharmacology and effects.